EDGAR Filing Documents for 0001104659-18-060601

Form 8-K - Current report:

SEC Accession No. 0001104659-18-060601

Filing Date

2018-10-05

Accepted

2018-10-04 19:22:41

Documents

Period of Report

2018-10-04

Items

Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a18-36350_18k.htm	8-K	33976
2	EX-2.1	a18-36350_1ex2d1.htm	EX-2.1	910832
3	EX-99.1	a18-36350_1ex99d1.htm	EX-99.1	9443
4	GRAPHIC	g363501mmi001.jpg	GRAPHIC	2847
	Complete submission text file	0001104659-18-060601.txt		959623

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879

Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200

Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)